Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium

Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium

Escalating resistance to azithromycin and moxifloxacin is being reported for Mycoplasma genitalium in the Asia-Pacific region. Analyzing 140 infections, we found pretreatment fluoroquinolone-resistance mutations in parC (13.6%) and gyrA (5%). ParC S83 changes were associated with moxifloxacin failur...

Full description

Bibliographic Details
Main Authors: Gerald L. Murray, Catriona S. Bradshaw, Melanie Bissessor, Jennifer A. Danielewski, Suzanne M. Garland, Jørgen S. Jensen, Christopher K. Fairley, Sepehr N. Tabrizi
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2017-05-01
Series:Emerging Infectious Diseases
Subjects:
Mycoplasma genitalium
moxifloxacin
ParC
GyrA
antibiotic resistance
antimicrobial resistance
Online Access:https://wwwnc.cdc.gov/eid/article/23/5/16-1745_article

Internet

https://wwwnc.cdc.gov/eid/article/23/5/16-1745_article

Similar Items